Consistently, treatment of thyroid cancer cells with YK-4-279 for 24 h significantly decreased TERT expression in either TERT promoter-WT or TERT promoter-mutant cell lines in a dose-dependent manner (Figure 2B). The gene discussed is TERT; the disease is thyroid gland carcinoma.